The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global DNA Vaccines Market Research Report 2025
Synopsis
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
The global DNA Vaccines market was valued at US$ 4642 million in 2023 and is anticipated to reach US$ 7849.6 million by 2030, witnessing a CAGR of 7.7% during the forecast period 2024-2030.
Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.
This report aims to provide a comprehensive presentation of the global market for DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Vaccines.
Report Scope
The DNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Segment by Type
Recombinant Protein Vaccine
Gene-Based Vaccine
Segment by Application
Human
Animal
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
The global DNA Vaccines market was valued at US$ 4642 million in 2023 and is anticipated to reach US$ 7849.6 million by 2030, witnessing a CAGR of 7.7% during the forecast period 2024-2030.
Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.
This report aims to provide a comprehensive presentation of the global market for DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Vaccines.
Report Scope
The DNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Segment by Type
Recombinant Protein Vaccine
Gene-Based Vaccine
Segment by Application
Human
Animal
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 DNA Vaccines Market Overview
1.1 Product Overview and Scope of DNA Vaccines
1.2 DNA Vaccines Segment by Type
1.2.1 Global DNA Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 DNA Vaccines Segment by Application
1.3.1 Global DNA Vaccines Market Value by Application: (2024-2030)
1.3.2 Human
1.3.3 Animal
1.4 Global DNA Vaccines Market Size Estimates and Forecasts
1.4.1 Global DNA Vaccines Revenue 2019-2030
1.4.2 Global DNA Vaccines Sales 2019-2030
1.4.3 Global DNA Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 DNA Vaccines Market Competition by Manufacturers
2.1 Global DNA Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global DNA Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global DNA Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global DNA Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DNA Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DNA Vaccines, Product Type & Application
2.7 DNA Vaccines Market Competitive Situation and Trends
2.7.1 DNA Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest DNA Vaccines Players Market Share by Revenue
2.7.3 Global DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 DNA Vaccines Retrospective Market Scenario by Region
3.1 Global DNA Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global DNA Vaccines Global DNA Vaccines Sales by Region: 2019-2030
3.2.1 Global DNA Vaccines Sales by Region: 2019-2024
3.2.2 Global DNA Vaccines Sales by Region: 2025-2030
3.3 Global DNA Vaccines Global DNA Vaccines Revenue by Region: 2019-2030
3.3.1 Global DNA Vaccines Revenue by Region: 2019-2024
3.3.2 Global DNA Vaccines Revenue by Region: 2025-2030
3.4 North America DNA Vaccines Market Facts & Figures by Country
3.4.1 North America DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America DNA Vaccines Sales by Country (2019-2030)
3.4.3 North America DNA Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe DNA Vaccines Market Facts & Figures by Country
3.5.1 Europe DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe DNA Vaccines Sales by Country (2019-2030)
3.5.3 Europe DNA Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DNA Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific DNA Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific DNA Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America DNA Vaccines Market Facts & Figures by Country
3.7.1 Latin America DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America DNA Vaccines Sales by Country (2019-2030)
3.7.3 Latin America DNA Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DNA Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa DNA Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa DNA Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global DNA Vaccines Sales by Type (2019-2030)
4.1.1 Global DNA Vaccines Sales by Type (2019-2024)
4.1.2 Global DNA Vaccines Sales by Type (2025-2030)
4.1.3 Global DNA Vaccines Sales Market Share by Type (2019-2030)
4.2 Global DNA Vaccines Revenue by Type (2019-2030)
4.2.1 Global DNA Vaccines Revenue by Type (2019-2024)
4.2.2 Global DNA Vaccines Revenue by Type (2025-2030)
4.2.3 Global DNA Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global DNA Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global DNA Vaccines Sales by Application (2019-2030)
5.1.1 Global DNA Vaccines Sales by Application (2019-2024)
5.1.2 Global DNA Vaccines Sales by Application (2025-2030)
5.1.3 Global DNA Vaccines Sales Market Share by Application (2019-2030)
5.2 Global DNA Vaccines Revenue by Application (2019-2030)
5.2.1 Global DNA Vaccines Revenue by Application (2019-2024)
5.2.2 Global DNA Vaccines Revenue by Application (2025-2030)
5.2.3 Global DNA Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global DNA Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck DNA Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK DNA Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi DNA Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Corporation Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zoties DNA Vaccines Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Elanco DNA Vaccines Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer-Ingelheim
6.6.1 Boehringer-Ingelheim Corporation Information
6.6.2 Boehringer-Ingelheim Description and Business Overview
6.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer-Ingelheim DNA Vaccines Product Portfolio
6.6.5 Boehringer-Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.6.1 Indian Immunologicals Corporation Information
6.6.2 Indian Immunologicals Description and Business Overview
6.6.3 Indian Immunologicals DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Indian Immunologicals DNA Vaccines Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 Plumbline Life Sciences
6.8.1 Plumbline Life Sciences Corporation Information
6.8.2 Plumbline Life Sciences Description and Business Overview
6.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Plumbline Life Sciences DNA Vaccines Product Portfolio
6.8.5 Plumbline Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DNA Vaccines Industry Chain Analysis
7.2 DNA Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DNA Vaccines Production Mode & Process
7.4 DNA Vaccines Sales and Marketing
7.4.1 DNA Vaccines Sales Channels
7.4.2 DNA Vaccines Distributors
7.5 DNA Vaccines Customers
8 DNA Vaccines Market Dynamics
8.1 DNA Vaccines Industry Trends
8.2 DNA Vaccines Market Drivers
8.3 DNA Vaccines Market Challenges
8.4 DNA Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global DNA Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global DNA Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global DNA Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global DNA Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global DNA Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global DNA Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global DNA Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market DNA Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of DNA Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of DNA Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of DNA Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of DNA Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global DNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global DNA Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global DNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 18. Global DNA Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global DNA Vaccines Sales by Region (2025-2030) & (K Units)
Table 20. Global DNA Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global DNA Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global DNA Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global DNA Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global DNA Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America DNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 27. North America DNA Vaccines Sales by Country (2025-2030) & (K Units)
Table 28. North America DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe DNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 32. Europe DNA Vaccines Sales by Country (2025-2030) & (K Units)
Table 33. Europe DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific DNA Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific DNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific DNA Vaccines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific DNA Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific DNA Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America DNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America DNA Vaccines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa DNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa DNA Vaccines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global DNA Vaccines Sales (K Units) by Type (2019-2024)
Table 51. Global DNA Vaccines Sales (K Units) by Type (2025-2030)
Table 52. Global DNA Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global DNA Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global DNA Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global DNA Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global DNA Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global DNA Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global DNA Vaccines Price (USD/Unit) by Type (2019-2024)
Table 59. Global DNA Vaccines Price (USD/Unit) by Type (2025-2030)
Table 60. Global DNA Vaccines Sales (K Units) by Application (2019-2024)
Table 61. Global DNA Vaccines Sales (K Units) by Application (2025-2030)
Table 62. Global DNA Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global DNA Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global DNA Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global DNA Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global DNA Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global DNA Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global DNA Vaccines Price (USD/Unit) by Application (2019-2024)
Table 69. Global DNA Vaccines Price (USD/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Merck DNA Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. GSK DNA Vaccines Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Sanofi DNA Vaccines Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Zoties Corporation Information
Table 86. Zoties Description and Business Overview
Table 87. Zoties DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Zoties DNA Vaccines Product
Table 89. Zoties Recent Developments/Updates
Table 90. Elanco Corporation Information
Table 91. Elanco Description and Business Overview
Table 92. Elanco DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Elanco DNA Vaccines Product
Table 94. Elanco Recent Developments/Updates
Table 95. Boehringer-Ingelheim Corporation Information
Table 96. Boehringer-Ingelheim Description and Business Overview
Table 97. Boehringer-Ingelheim DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Boehringer-Ingelheim DNA Vaccines Product
Table 99. Boehringer-Ingelheim Recent Developments/Updates
Table 100. Indian Immunologicals Corporation Information
Table 101. Indian Immunologicals Description and Business Overview
Table 102. Indian Immunologicals DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Indian Immunologicals DNA Vaccines Product
Table 104. Indian Immunologicals Recent Developments/Updates
Table 105. Plumbline Life Sciences Corporation Information
Table 106. Plumbline Life Sciences Description and Business Overview
Table 107. Plumbline Life Sciences DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Plumbline Life Sciences DNA Vaccines Product
Table 109. Plumbline Life Sciences Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. DNA Vaccines Distributors List
Table 113. DNA Vaccines Customers List
Table 114. DNA Vaccines Market Trends
Table 115. DNA Vaccines Market Drivers
Table 116. DNA Vaccines Market Challenges
Table 117. DNA Vaccines Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of DNA Vaccines
Figure 2. Global DNA Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global DNA Vaccines Market Share by Type in 2023 & 2030
Figure 4. Recombinant Protein Vaccine Product Picture
Figure 5. Gene-Based Vaccine Product Picture
Figure 6. Global DNA Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global DNA Vaccines Market Share by Application in 2023 & 2030
Figure 8. Human
Figure 9. Animal
Figure 10. Global DNA Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global DNA Vaccines Market Size (2019-2030) & (US$ Million)
Figure 12. Global DNA Vaccines Sales (2019-2030) & (K Units)
Figure 13. Global DNA Vaccines Average Price (USD/Unit) & (2019-2030)
Figure 14. DNA Vaccines Report Years Considered
Figure 15. DNA Vaccines Sales Share by Manufacturers in 2023
Figure 16. Global DNA Vaccines Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest DNA Vaccines Players: Market Share by Revenue in 2023
Figure 18. DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global DNA Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America DNA Vaccines Sales Market Share by Country (2019-2030)
Figure 21. North America DNA Vaccines Revenue Market Share by Country (2019-2030)
Figure 22. U.S. DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe DNA Vaccines Sales Market Share by Country (2019-2030)
Figure 25. Europe DNA Vaccines Revenue Market Share by Country (2019-2030)
Figure 26. Germany DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific DNA Vaccines Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific DNA Vaccines Revenue Market Share by Region (2019-2030)
Figure 33. China DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America DNA Vaccines Sales Market Share by Country (2019-2030)
Figure 44. Latin America DNA Vaccines Revenue Market Share by Country (2019-2030)
Figure 45. Mexico DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa DNA Vaccines Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa DNA Vaccines Revenue Market Share by Country (2019-2030)
Figure 50. Turkey DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of DNA Vaccines by Type (2019-2030)
Figure 54. Global Revenue Market Share of DNA Vaccines by Type (2019-2030)
Figure 55. Global DNA Vaccines Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of DNA Vaccines by Application (2019-2030)
Figure 57. Global Revenue Market Share of DNA Vaccines by Application (2019-2030)
Figure 58. Global DNA Vaccines Price (USD/Unit) by Application (2019-2030)
Figure 59. DNA Vaccines Value Chain
Figure 60. DNA Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
